Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced its participation in three upcoming conferences in February:
•2015 Leerink Global Healthcare Conference at the Waldorf Astoria in New York on Thursday, February 12 at 2:15 p.m. EST.
Help employers find you! Check out all the jobs and post your resume.
